Download PDF
CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2021; 5(02): 127-130
DOI: 10.1055/s-0041-1730850
Case Report

Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion

Kazuki Matsushita
1   Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Abeno-ku, Osaka city, Osaka, Japan
,
Ken Kageyama
1   Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Abeno-ku, Osaka city, Osaka, Japan
,
Natsuhiko Kameda
2   Department of Gastroenterology, Naniwa Ikuno Hospital, Naniwa-ku, Osaka city, Osaka, Japan
,
Yurina Koizumi
3   Department of Hepatology, Osaka City General Hospital, Miyakojima Hon-Dori, Miyakojima-ku, Osaka city, Osaka, Japan
,
Akira Yamamoto
1   Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Abeno-ku, Osaka city, Osaka, Japan
› Author Affiliations Funding declared.
› Further Information
   Permissions and Reprints

Abstract

Hepatocellular carcinoma (HCC) with bile duct invasion is considered rare. A case in which a fragment of intraductal tumor dropped into the common bile duct after transarterial chemoembolization (TACE) and caused abdominal pain, and obstructive jaundice secondary to biliary obstruction is presented. This case was successfully managed by emergent endoscopic sphincterotomy. Physicians should recognize one of the complications due to TACE for HCC with intraductal tumor invasion.

Keywords

hepatocellular carcinoma - bile duct invasion - transarterial chemoembolization


Publication History

Article published online:
30 June 2021

© 2021. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Hiraki T, Sakurai J, Gobara H. et al. Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter chemoembolization causing obstructive jaundice and acute pancreatitis. J Vasc Interv Radiol 2006; 17 (03) 583-585
    CrossrefPubMedGoogle Scholar
  • 2 Okuda M, Miyayama S, Yamashiro M. et al. Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 2010; 33 (03) 619-623
    CrossrefPubMedGoogle Scholar
  • 3 Park HC, Park HB, Chung CY. et al. Acute obstructive cholangitis complicated by tumor migration after transarterial chemoembolization: a case report and literature review. Korean J Gastroenterol 2014; 63 (03) 171-175
    CrossrefPubMedGoogle Scholar
  • 4 Choi KH, Cho YK, An JK, Woo JJ, Kim HS, Choi YS. Acute obstructive cholangitis after transarterial chemoembolization: the effect of percutaneous transhepatic removal of tumor fragment. Korean J Radiol 2009; 10 (02) 197-201
    CrossrefPubMedGoogle Scholar
  • 5 Hyo JP, Ji HS. Intraductal migration of necrotic hepatocellular carcinoma: a possible cause of obstructive cholangitis after chemoembolization. Gastrointest Interv. 2018; 7: 29-33
    CrossrefPubMedGoogle Scholar
  • 6 Kim GM, Kim HC, Hur S, Lee M, Jae HJ, Chung JW. Sloughing of biliary tumour ingrowth of hepatocellular carcinoma after chemoembolization. Eur Radiol 2016; 26 (06) 1760-1765
    CrossrefPubMedGoogle Scholar
  • 7 Miyayama S, Yamashiro M, Nagai K. et al. Excretion of necrotic hepatocellular carcinoma tissues into the biliary system after transcatheter arterial chemoembolization. Hepatol Res 2017; 47 (13) 1390-1396
    CrossrefPubMedGoogle Scholar
  • 8 Spahr L, Frossard JL, Felley C, Brundler MA, Majno PE, Hadengue A. Biliary migration of hepatocellular carcinoma fragment after transcatheter arterial chemoembolization therapy. Eur J Gastroenterol Hepatol 2000; 12 (02) 243-244
    CrossrefPubMedGoogle Scholar
  • 9 Ridtitid W, Chittmittrapap S, Kriengkirakul C, Kongkam P, Janchai A, Rerknimitr R. Lipiodol as a marker for hepatocellular carcinoma migrating into the bile duct. Endoscopy 2010; 42 (Suppl. 02) E233-E234
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Sasaki T, Takahara N, Kawaguchi Y. et al. Biliary tumor thrombus of hepatocellular carcinoma containing lipiodol mimicking a calcified bile duct stone. Endoscopy 2012; 44 (Suppl. 02) E250-E251
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Matsumoto K, Osanai M, Maguchi H. Biliary tumor fragment of hepatocellular carcinoma containing lipiodol mimicking a bile duct stone. Dig Endosc 2014; 26 (02) 295-296
    CrossrefPubMedGoogle Scholar
  • 12 Ghosn M, Mulé S, Chalaye J. et al. Acute biliary obstruction after transarterial radioembolization with yttrium-90. J Vasc Interv Radiol 2019; 30 (12) 2043-2045
    CrossrefPubMedGoogle Scholar
  • 13 Park J, Kim HC, Lee JH. et al. Chemoembolisation for hepatocellular carcinoma with bile duct invasion: is preprocedural biliary drainage mandatory?. Eur Radiol 2018; 28 (04) 1540-1550
    CrossrefPubMedGoogle Scholar